Who owns the NXACT trademark?

The NXACT trademark is owned by Nurix Therapeutics, Inc..

What is the serial number for NXACT?

The USPTO serial number for NXACT is 88622881.

What is the registration number for NXACT?

NXACT is registered under USPTO registration number 6521401.

NXA

USPTO Trademark Record

REGISTERED

NXACT

Q: What class is the NXACT trademark registered in?

The NXACT trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 88622881·Reg 6521401·Filed Sep 19, 2019

Owner Nurix Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

NXACT (Serial No. 88622881), Registration No. 6521401, is a registered US trademark filed on Sep 19, 2019 by Nurix Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

early section 8: October 12, 2027

Mark Intelligence

NXACT (Reg. #6521401) is a registered US trademark that has been protecting its owner, Nurix Therapeutics, Inc., since 2019. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 19, 2019

SERIAL

88622881

REG#

6521401

REGISTERED

Oct 12, 2021

Owner

Applicant

Nurix Therapeutics, Inc.

Entity

Corporation

State

Address

1600 Sierra Point Parkway, Brisbane, CA, 94005

Country

Attorney

NameGazal Pour-Moezzi

Law firm

Gazal Pour-Moezzi Sheppard Mullin Richter & Hampton LLP

Docket

69SJ-304455

Address

650 Town Center Drive, 10th Floor, Costa Mesa, CA 92626, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateSep 19, 2019

Serial Number88622881

Registration No.6521401

Registration DateOct 12, 2021

Status DateOct 12, 2021

Published for OppositionDec 15, 2020

Mark TypeStandard characters

Attorney Docket69SJ-304455

Status DescriptionLive and registered

Filing Signals

FILED

2019

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Jul 28, 2021

First use in commerce: Jul 28, 2021

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Jul 28, 2021

First use in commerce: Jul 28, 2021

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

32 events

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Nov 24, 2025

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Nov 24, 2025

TEAS CHANGE OF OWNER ADDRESS RECEIVED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Nov 24, 2025

TEAS CHANGE OF CORRESPONDENCE RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Nov 24, 2025

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Nov 24, 2025

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

REGISTERED-PRINCIPAL REGISTER

Oct 12, 2021

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Sep 09, 2021

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Sep 08, 2021

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 09, 2021

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Aug 09, 2021

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Jul 29, 2021

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Jul 29, 2021

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 09, 2021

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 15, 2020

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Dec 15, 2020

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 25, 2020

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 10, 2020

APPROVED FOR PUB - PRINCIPAL REGISTER

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

Nov 05, 2020

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

ASSIGNED TO LIE

Nov 04, 2020

ASSIGNED TO LIE

EXAMINERS AMENDMENT -WRITTEN

Mar 09, 2020

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Mar 09, 2020

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 09, 2020

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Mar 09, 2020

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

LETTER OF SUSPENSION E-MAILED

Mar 09, 2020

LETTER OF SUSPENSION E-MAILED

SUSPENSION LETTER WRITTEN

Mar 09, 2020

SUSPENSION LETTER WRITTEN

EXAMINER'S AMENDMENT ENTERED

Mar 09, 2020

EXAMINER'S AMENDMENT ENTERED

NON-FINAL ACTION WRITTEN

Dec 26, 2019

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Dec 26, 2019

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 26, 2019

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Dec 19, 2019

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 25, 2019

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Sep 23, 2019

NEW APPLICATION ENTERED

NXACT

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Nurix Therapeutics, Inc.

Other Marks by Gazal Pour-Moezzi

Resources

Company